albuterol has been researched along with Bradyarrhythmia in 7 studies
Albuterol: A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.
albuterol : A member of the class of phenylethanolamines that is 4-(2-amino-1-hydroxyethyl)-2-(hydroxymethyl)phenol having a tert-butyl group attached to the nirogen atom. It acts as a beta-adrenergic agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).
| Excerpt | Relevance | Reference |
|---|---|---|
| "The charts of CSCI patients admitted to a Level I trauma center from February 2008 through March 2012 were reviewed for demographics, episodes of symptomatic bradycardia (defined as heart rate < 60 beats per minute and systolic blood pressure < 90 mm Hg), use of enteral albuterol, hospital days requiring chronotropic use, and total atropine administered." | 7.80 | Enteral albuterol decreases the need for chronotropic agents in patients with cervical spinal cord injury-induced bradycardia. ( Berry, AJ; Cocanour, CS; Duby, JJ; Evans, CH; Schermer, CR, 2014) |
| "Albuterol administration in ASCI is a safe and feasible treatment for bradycardia, given that no significant side effects, such as hyperglycemia, hypokalemia, or tachycardia, were observed." | 4.12 | Impact of Enteral Albuterol on Bradycardic Events After Acute Cervical Spinal Cord Injury. ( Badjatia, N; Chang, WT; Gupta, S; Hassan, M; Jenkins, R; Lim-Hing, K; Massetti, J; Paganelli, P; Pajoumand, M; Parikh, G; Schwartzbauer, G; Stein, D, 2022) |
| "The charts of CSCI patients admitted to a Level I trauma center from February 2008 through March 2012 were reviewed for demographics, episodes of symptomatic bradycardia (defined as heart rate < 60 beats per minute and systolic blood pressure < 90 mm Hg), use of enteral albuterol, hospital days requiring chronotropic use, and total atropine administered." | 3.80 | Enteral albuterol decreases the need for chronotropic agents in patients with cervical spinal cord injury-induced bradycardia. ( Berry, AJ; Cocanour, CS; Duby, JJ; Evans, CH; Schermer, CR, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Lim-Hing, K | 1 |
| Massetti, J | 1 |
| Pajoumand, M | 1 |
| Gupta, S | 1 |
| Jenkins, R | 1 |
| Hassan, M | 1 |
| Paganelli, P | 1 |
| Parikh, G | 1 |
| Chang, WT | 1 |
| Schwartzbauer, G | 1 |
| Stein, D | 1 |
| Badjatia, N | 1 |
| Evans, CH | 1 |
| Duby, JJ | 1 |
| Berry, AJ | 1 |
| Schermer, CR | 1 |
| Cocanour, CS | 1 |
| Witharana, EW | 1 |
| Wijetunga, WM | 1 |
| Sathanandan, PP | 1 |
| Wijesinghe, SK | 1 |
| Wickramaratne, LG | 1 |
| Rollstin, A | 1 |
| Carey, MC | 1 |
| Doherty, G | 1 |
| Tawil, I | 1 |
| Marinaro, J | 1 |
| Jaeggi, ET | 1 |
| Chitayat, D | 1 |
| Taylor, G | 1 |
| Somes, J | 1 |
| Donatelli, NS | 1 |
| Arora, P | 1 |
| Kumar, V | 1 |
| Dubey, NK | 1 |
| Mahesh, K | 1 |
7 other studies available for albuterol and Bradyarrhythmia
| Article | Year |
|---|---|
Impact of Enteral Albuterol on Bradycardic Events After Acute Cervical Spinal Cord Injury.
Topics: Adolescent; Adult; Aged; Albuterol; Bradycardia; Cervical Cord; Female; Humans; Hyperglycemia; Hypok | 2022 |
Enteral albuterol decreases the need for chronotropic agents in patients with cervical spinal cord injury-induced bradycardia.
Topics: Administration, Oral; Adrenergic beta-2 Receptor Agonists; Adult; Aged; Albuterol; Bradycardia; Cerv | 2014 |
Cardiac toxicity with nodal bradycardia due to Panama rubber (Castilla elastica: Moraceae) poisoning.
Topics: Adrenergic beta-2 Receptor Agonists; Aged; Albuterol; Anti-Arrhythmia Agents; Atropine; Bradycardia; | 2014 |
Oral albuterol to treat symptomatic bradycardia in acute spinal cord injury.
Topics: Administration, Oral; Adult; Albuterol; Bradycardia; Bronchodilator Agents; Female; Humans; Male; Mi | 2016 |
Atrial standstill associated with loss of atrial myocytes: a rare cause of fetal bradyarrhythmia.
Topics: Adrenergic beta-Agonists; Albuterol; Bradycardia; Fatal Outcome; Fetal Death; Heart Atria; Heart Blo | 2009 |
A geriatric patient with medication-mediated profound weakness.
Topics: Adrenergic beta-2 Receptor Agonists; Albuterol; Anti-Arrhythmia Agents; Anticonvulsants; Antihyperte | 2010 |
Nebulised salbutamol: an antidote for beta blockers.
Topics: Acute Disease; Administration, Inhalation; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Al | 1999 |